Mikatek 250mg Injection
Marketer
Smotec Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Mikatek 250mg Injection
Cefamandole nafate 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, skeletal, pulmonary (such as pneumonia), neurological, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administration, strictly under medical supervision, occurs via intravenous infusion or intramuscular injection. Consistent dosing, as directed, is crucial; premature cessation risks relapse or infection exacerbation. Typical side effects involve injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitates consultation. High dosages may induce vertigo, nephrotoxicity, and ototoxicity, necessitating diligent adherence to physician instructions, including potential monitoring of renal function, auditory acuity, and urinalysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Mikatek 250mg Injection
Infections caused by bacteria
Major Benefits of Mikatek 250mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Mikatek 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikatek 250mg Injection:
The medication will be administered by your physician or their assistant; self-medication is strictly prohibited.
How Mikatek 250mg Injection works:
Cefuroxime axetil 250mg injection is a bacterial growth inhibitor. Its mechanism of action involves disrupting the production of crucial bacterial proteins, thereby impairing essential bacterial processes.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Mikatek 250mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikatek 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in extreme, life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikatek 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administration of Mikatek 250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Patients with impaired kidney function should use Mikatek 250mg Injection judiciously. Dosage modification of Mikatek 250mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikatek 250mg injections appear to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mikatek 250mg Injection :
Omit a scheduled Mikatek 250mg Injection? Seek your physician's advice.
Facts to Know About Mikatek 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
| Behavioral Class | Aminoglycoside antibiotics |
3,018 People bought this recently